In order to evaluate whether the number of CBF neurons containing NGF receptors is altered early in the progression of AD, we examined tissue from RROS subjects clinically categorized as NCI, MCI, or AD (Gilmor et al., 1999). Here, CEBPZ is linked to Alzheimer disease.